Titration schedule of Rybelsus is as follows: Formulation R1 (3 mg, 7 mg, 14 mg) Weeks 14 (Days 130): 3 mg once daily (This is the starting dose that may not be effective for glycemic control) Weeks 58 (Days 3160): 7 mg once daily Weeks 9 and onwards (Day 61+): Maintain 7 mg once daily if adequate control is achieved Increase to 14 mg once daily if additional glycemic control needed Formulation R2 (1.5 mg, 4 mg, 9 mg) Week 14 (Days 130): 1.5 mg once daily Week 58 (Days 3160): 4 mg once daily Week 9 onward (Day 61+): Maintain 4 mg once daily if adequate control is achieved or, Increase to 9 mg once daily if additional glycemic control is needed Why a conversion chart matters Liraglutide, semaglutide, and dulaglutide are GLP-1 agonists, but they have different active ingredients, indications, efficacy, and potencies
While its not suitable for Type 1 Diabetes, it can be a powerful option for managing Type 2 Diabetes and obesity under medical guidance
People taking semaglutide may lose anywhere between 9.6%17.4% of their body weight within 68 weeks, while those taking Qsymia (phentermine/topiramate) may lose 5% to 10.6% within a year
This guide breaks down every meaningful difference between retatrutide and semaglutide
If youd like to learn more about the link between back pain and weight loss after medications like Wegovy, connect with our Hiram chiropractor at Cornerstone Chiropractic for support
